These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27941393)

  • 41. Effects of Transcutaneous Electrical Acupoint Stimulation on Patients with Stable Chronic Obstructive Pulmonary Disease: A Prospective, Single-Blind, Randomized, Placebo-Controlled Study.
    Liu X; Fan T; Lan Y; Dong S; Fu J; Mao B
    J Altern Complement Med; 2015 Oct; 21(10):610-6. PubMed ID: 26218785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
    Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
    Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
    Matsushima S; Inui N; Yasui H; Kono M; Nakamura Y; Toyoshima M; Shirai T; Suda T
    Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of long-acting bronchodilators and prednisolone on inspiratory lung function parameters in stable COPD.
    Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
    Pulm Pharmacol Ther; 2014 Aug; 28(2):158-64. PubMed ID: 24076367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bronchodilator response of advanced lung function parameters depending on COPD severity.
    Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dehydroepiandrosterone (DHEA) improves pulmonary hypertension in chronic obstructive pulmonary disease (COPD): a pilot study.
    Dumas de La Roque E; Savineau JP; Metivier AC; Billes MA; Kraemer JP; Doutreleau S; Jougon J; Marthan R; Moore N; Fayon M; Baulieu EÉ; Dromer C
    Ann Endocrinol (Paris); 2012 Feb; 73(1):20-5. PubMed ID: 22280813
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study.
    Lee JS; Rosengart MR; Kondragunta V; Zhang Y; McMurray J; Branch RA; Choi AM; Sciurba FC
    Respir Res; 2007 Sep; 8(1):64. PubMed ID: 17868461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.
    Ichinose M; Takizawa A; Izumoto T; Tadayasu Y; Hamilton AL; Kunz C; Fukuchi Y
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1673-83. PubMed ID: 26316741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV vasculopathy: role of mononuclear cell-associated Krüppel-like factors 2 and 4.
    Hale AT; Longenecker CT; Jiang Y; Debanne SM; Labatto DE; Storer N; Hamik A; McComsey GA
    AIDS; 2015 Aug; 29(13):1643-50. PubMed ID: 26372274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative emphysema assessment of pulmonary function impairment by computed tomography in chronic obstructive pulmonary disease.
    Wang G; Wang L; Ma Z; Zhang C; Deng K
    J Comput Assist Tomogr; 2015; 39(2):171-5. PubMed ID: 25474145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomised, placebo-controlled, Phase II, dose-ranging trial of once-daily treatment with olodaterol, a novel long-acting β2-agonist, for 4 weeks in patients with chronic obstructive pulmonary disease.
    Maleki-Yazdi MR; Beck E; Hamilton AL; Korducki L; Koker P; Fogarty C
    Respir Med; 2015 May; 109(5):596-605. PubMed ID: 25829298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study.
    Kristoffersen US; Lebech AM; Mortensen J; Gerstoft J; Gutte H; Kjaer A
    Clin Physiol Funct Imaging; 2012 Jul; 32(4):288-95. PubMed ID: 22681606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study.
    Incorvaia C; Russo A; Foresi A; Berra D; Elia R; Passalacqua G; Riario-Sforza GG; Ridolo E
    Eur J Phys Rehabil Med; 2014 Aug; 50(4):419-26. PubMed ID: 24691247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
    Kitaguchi Y; Yasuo M; Hanaoka M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():991-7. PubMed ID: 27274220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection.
    Bobbio A; Chetta A; Carbognani P; Internullo E; Verduri A; Sansebastiano G; Rusca M; Olivieri D
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):754-8. PubMed ID: 16140541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.
    Aberg JA; Sponseller CA; Ward DJ; Kryzhanovski VA; Campbell SE; Thompson MA
    Lancet HIV; 2017 Jul; 4(7):e284-e294. PubMed ID: 28416195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
    Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
    Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.
    Calverley PM; Sanchez-Toril F; McIvor A; Teichmann P; Bredenbroeker D; Fabbri LM
    Am J Respir Crit Care Med; 2007 Jul; 176(2):154-61. PubMed ID: 17463412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
    Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.